Proteomics

Dataset Information

0

Regulation of lipid homeostasis in treatment-resistant prostate cancer


ABSTRACT: Despite the clinical success of Androgen Receptor (AR)-targeted therapies, reactivation of AR signalling remains the main driver of castration-resistant prostate cancer (CRPC) progression. In this study, we performed a comprehensive unbiased characterisation of LNCaP cells chronically exposed to multiple AR inhibitors (ARI). Combined proteomics and metabolomics analyses implicated an acquired metabolic phenotype common in ARI-resistant cells and associated with perturbed glucose and lipid metabolism. To exploit this phenotype, we delineated a subset of proteins consistently associated with ARI resistance.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell Of Prostate

DISEASE(S): Prostate Cancer

SUBMITTER: Sergio Lilla  

LAB HEAD: Sara Rossana Zanivan

PROVIDER: PXD016836 | Pride | 2020-05-26

REPOSITORIES: Pride

altmetric image

Publications


Despite the clinical success of Androgen Receptor (AR)-targeted therapies, reactivation of AR signalling remains the main driver of castration-resistant prostate cancer (CRPC) progression. In this study, we perform a comprehensive unbiased characterisation of LNCaP cells chronically exposed to multiple AR inhibitors (ARI). Combined proteomics and metabolomics analyses implicate an acquired metabolic phenotype common in ARI-resistant cells and associated with perturbed glucose and lipid metabolis  ...[more]

Similar Datasets

2022-10-14 | PXD021405 | Pride
2022-04-06 | PXD021428 | Pride
2018-12-01 | E-MTAB-5121 | biostudies-arrayexpress
2021-03-01 | PXD011974 | Pride
2011-04-01 | E-GEOD-16525 | biostudies-arrayexpress
2017-04-28 | E-GEOD-68353 | biostudies-arrayexpress
2017-10-02 | E-MTAB-5754 | biostudies-arrayexpress
2024-10-30 | E-MTAB-13909 | biostudies-arrayexpress
2021-09-09 | PXD020410 | Pride
2019-08-19 | PXD013924 | Pride